<DOC>
	<DOCNO>NCT01213433</DOCNO>
	<brief_summary>This phase IV one-arm study aim recruit 50 patient assess efficacy AQ+AS patient positive RDT diagnosis malaria Nanoro , Burkina Faso .</brief_summary>
	<brief_title>Amodiaquine+Artesunate Uncomplicated Malaria Treatment</brief_title>
	<detailed_description />
	<mesh_term>Malaria</mesh_term>
	<mesh_term>Amodiaquine</mesh_term>
	<mesh_term>Artesunate</mesh_term>
	<mesh_term>Artemisinins</mesh_term>
	<mesh_term>Amodiaquine , artesunate drug combination</mesh_term>
	<criteria>Males Females age 6 month . Body weight 5 Kg . RDT positive test . Fever ( axillary temperature ≥ 37.5°C ) history fever previous 24 hour . Signed ( thumbprinted whenever patient illiterate ) inform consent . Patients ' willingness ability comply study protocol duration study . Participation investigational drug study ( antimalarial others ) previous 30 day . Known hypersensitivity study drug . Severe malaria . Danger sign : able drink breastfeed , vomit ( &gt; twice 24hours ) , recent history convulsion ( &gt; 1 24h ) , unconscious state , unable sit stand . Known intercurrent illness condition ( cardiac , renal , hepatic disease ) judgement investigator would place subject undue risk interfere result study . Severe malnutrition ( defined weight height &lt; 70 % median NCHS/WHO reference ) .</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>